Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iradimed (IRMD) Return on Sales (2016 - 2025)

Historic Return on Sales for Iradimed (IRMD) over the last 13 years, with Q3 2025 value amounting to 0.26%.

  • Iradimed's Return on Sales fell 100.0% to 0.26% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.25%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.25% for FY2024, which is 100.0% up from last year.
  • According to the latest figures from Q3 2025, Iradimed's Return on Sales is 0.26%, which was down 100.0% from 0.28% recorded in Q2 2025.
  • In the past 5 years, Iradimed's Return on Sales ranged from a high of 0.33% in Q4 2021 and a low of 0.15% during Q2 2021
  • In the last 5 years, Iradimed's Return on Sales had a median value of 0.25% in 2022 and averaged 0.24%.
  • In the last 5 years, Iradimed's Return on Sales soared by 4600bps in 2021 and then tumbled by -800bps in 2022.
  • Over the past 5 years, Iradimed's Return on Sales (Quarter) stood at 0.33% in 2021, then fell by -25bps to 0.25% in 2022, then dropped by -28bps to 0.18% in 2023, then increased by 28bps to 0.23% in 2024, then grew by 15bps to 0.26% in 2025.
  • Its last three reported values are 0.26% in Q3 2025, 0.28% for Q2 2025, and 0.24% during Q1 2025.